The business in Romania blog writes about the Romanian business landscape, doing business in Romania, investing in Romania business and debating on business issues in Romania. Check this Blog's Policy here.
Sitemap | Feedback | Doing Business in Romania report | Opening a Business in Romania | RSS for this Blog
Monday, March 14, 2005
The Financial Investment Company (SIF) Transilvania Friday bought 2 percent in the Bucharest-based pharmaceutical producer Biofarm.
The transaction was worth 20 billion ROL (560,000 euros), at a price of 4,000 ROL per share, according to a release the investment company sent to the Bucharest Stock Exchange.
SIF Oltenia and SIF Banat Crisana gave the purchase start six weeks ago when they acquired around 13% in Biofarm for a total deal of 3.5 million euros.
SIF Muntenia has also become a Biofarm shareholder after buying 2% in the company for 640,000 euros.
Posted by Iulia Rasoiu : 3/14/2005 02:17:00 pm
06/01/2004 - 07/01/2004
The CSR awards in Romania
Romania at CeBIT
Elran to invest in Romanian TV venture
Electrica branches could finalize privatization ar...
New director for Generali Asigurari
Romexterra Bank is planning to be listed on BVB.
Flat tax increases wages by 5.2%
Less Shopping in Rates
Privatization authorities plan merger to improve r...
BNR opens Inter-banking market to foreign banks
Publications & Media
This website is proud to be designed by Mihai Dragan
I usually listen to THIS kind of music.